Pliant Therapeutics Inc. Common Stock is a biopharmaceutical company focused on discovering and developing novel treatments for fibrosis, an underlying cause of several diseases. Through its innovative approach, the company aims to improve patients’ lives by targeting and inhibiting the activation of specific proteins involved in fibrotic processes.
- Latest
- Trending
